since 1980, medifast, inc.(nyse: med) has been a brand recommended by 20,000 doctors. developed by a physician, medifast is a clinically proven nutrition and weight loss company based in maryland. we change lives by producing results and helping those succeed. because everyone has different goals and ways of learning, we offer several support programs as you choose health with medifast. we believe that healthier people are happier people. everyone has the right to feel good about themselves. our vision is to create a world where it's easy to take control of your own well-being. we're on a mission to empower people with the right opportunities to enjoy the healthy life they deserve. we see it every day. the ear-to-ear grin. the “holding back the tears” pride. the glow of pure joy when someone reaches their weight-loss goals. their whole life gets better, and so does yours, because you helped them get there. if you’d like to spend every day helping to change people’s lives for the better

Company profile
Ticker
MED
Exchange
Website
CEO
Daniel Chard
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
HEALTHRITE INC
SEC CIK
Corporate docs
Subsidiaries
Corporate Events, Inc. • Jason Enterprises, Inc. • Jason Pharmaceuticals, Inc. • Jason Properties, LLC • OPTAVIA, LLC • OPTAVIA Health Consultation (Shanghai) Co., Ltd. • OPTAVIA (Hong Kong) Limited • OPTAVIA (Singapore) PTE. LTD • Seven Crondall Associates, LLC ...
IRS number
133714405
MED stock data
Latest filings (excl ownership)
8-K
Medifast Announces Quarterly Dividend
7 Sep 23
8-K
Medifast Announces Second Quarter 2023 Financial Results
7 Aug 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
8-K
Medifast Announces Quarterly Dividend
15 Jun 23
8-K
Medifast Enhances “Fuel for the Future” Program to Position the Business for Long-term Sustainable Growth
1 Jun 23
10-Q
2023 Q1
Quarterly report
1 May 23
8-K
Medifast Announces First Quarter 2023
1 May 23
DEF 14A
Definitive proxy
1 May 23
DEFA14A
Additional proxy soliciting materials
1 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
Transcripts
MED
Earnings call transcript
2023 Q2
7 Aug 23
MED
Earnings call transcript
2023 Q1
1 May 23
MED
Earnings call transcript
2022 Q4
21 Feb 23
MED
Earnings call transcript
2022 Q3
4 Nov 22
MED
Earnings call transcript
2022 Q2
4 Aug 22
MED
Earnings call transcript
2022 Q1
3 May 22
MED
Earnings call transcript
2021 Q4
24 Feb 22
MED
Earnings call transcript
2021 Q3
5 Nov 21
MED
Earnings call transcript
2021 Q2
5 Aug 21
MED
Earnings call transcript
2021 Q1
4 May 21
Latest ownership filings
4
Jonathan Barrett MacKenzie
15 Sep 23
4
JEFFREY J BROWN
16 Aug 23
144
Notice of proposed sale of securities
14 Aug 23
4
JEFFREY J BROWN
10 Aug 23
4
SCOTT SCHLACKMAN
10 Aug 23
4
Andrea B Thomas
10 Aug 23
4
Ming Xian
10 Aug 23
4
Michael A. Hoer
10 Aug 23
4
James P. Maloney
24 Jul 23
4
Ming Xian
20 Jun 23
Financial summary
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q2 2023
87.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 230 |
Opened positions | 32 |
Closed positions | 61 |
Increased positions | 86 |
Reduced positions | 76 |
13F shares | Current |
---|---|
Total value | 863.00 bn |
Total shares | 9.47 mm |
Total puts | 315.80 k |
Total calls | 107.50 k |
Total put/call ratio | 2.9 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 1.71 mm | $157.60 bn |
Vanguard | 1.65 mm | $152.39 bn |
Renaissance Technologies | 680.61 k | $64.10 bn |
STT State Street | 381.76 k | $35.81 bn |
MS Morgan Stanley | 353.45 k | $32.57 bn |
Dimensional Fund Advisors | 337.30 k | $31.09 bn |
Pacer Advisors | 241.91 k | $22.29 bn |
Geode Capital Management | 226.38 k | $20.86 bn |
BK Bank Of New York Mellon | 190.36 k | $17.54 bn |
Citadel Advisors | 171.04 k | $15.76 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Sep 23 | Jonathan Barrett MacKenzie | Common Stock | Payment of exercise | Dispose F | No | No | 81.08 | 10 | 810.80 | 1,486 |
15 Aug 23 | Brown Jeffrey J | Common Stock | Sell | Dispose S | Yes | No | 90.47 | 13,330 | 1.21 mm | 0.638 |
15 Aug 23 | Brown Jeffrey J | Common Stock | Sell | Dispose S | Yes | No | 89.79 | 9,832 | 882.82 k | 13,330.638 |
14 Aug 23 | Brown Jeffrey J | Common Stock | Sell | Dispose S | Yes | No | 92.6 | 15,154 | 1.40 mm | 23,162.638 |
8 Aug 23 | Xian Ming | RSU Common Stock | Buy | Acquire P | No | No | 89.42 | 36.643 | 3.28 k | 4,764.477 |
8 Aug 23 | Hoer Michael A. | Common Stock | Buy | Acquire P | No | No | 89.42 | 37.644 | 3.37 k | 8,325.709 |
8 Aug 23 | Schlackman Scott | Common Stock | Buy | Acquire P | No | No | 89.42 | 39.824 | 3.56 k | 10,485.061 |
News
Wall Street's Most Accurate Analysts Say Hold These 3 Risk Off Stocks Delivering High-Dividend Yields
22 Sep 23
Friday Is Your Last Chance To Buy Medifast Before The Dividend Payout
13 Sep 23
Electronic Arts, Tractor Supply And 2 Other Stocks Insiders Are Selling
17 Aug 23
A Look Into Consumer Cyclical Sector Value Stocks
15 Aug 23
DA Davidson Maintains Neutral on Medifast, Lowers Price Target to $80
8 Aug 23
Press releases
OPTAVIA ACTIVE™ Now Available
13 Sep 23
Medifast Announces Quarterly Dividend
7 Sep 23
Medifast Survey Finds 8 out of 10 U.S. Adults say Practicing Daily "Self-Care Habits" is a Priority
7 Sep 23
Medifast Announces Second Quarter 2023 Financial Results
7 Aug 23
Medifast Expands into $30B Sports Nutrition Category with OPTAVIA ACTIVE™
27 Jul 23